The company lifted its revenue outlook for the year, saying it expects revenue to grow as much as 25% in 2026.
Moderna raises its revenue outlook — but all eyes are on what happens next with its cancer vaccine
More in Revenue
See all
Moderna (MRNA) Stock: Rally 7.38% as $1.3B Revenue and Positive Cancer Trial Results Boost Optimism
TLDR Moderna stock jumps 7.38% to $259.25 following strong third-quarter results. Quarterly revenue climbs 29% to $1.3 billion as overseas vaccine sales…
Blockonomi
3 hours ago
Moderna raises its revenue outlook — but all eyes are on what happens next with its experimental cancer vaccine
The company lifted its revenue outlook for the year, saying it expects revenue to grow as much as 25% in 2026.
MarketWatch
5 hours ago
TeraWulf’s bitcoin mining revenue falls 69% as HPC leasing surges amid Anthropic buildout
TeraWulf reported $63 million in artificial intelligence-related quarterly HPC lease revenue, up 774% year over year.
The Block
5 hours ago
